Finance for federal financing freeze medical marijuana research

Research into cancer, chronic pain, nausea and more will come to a standstill due to the freezing of the federal financing fragrance.

New research results validate cannabis can help cancer, chronic pain or more. It is an important alternative to avoid using opioid in pain after the operation. But now the deal financing has a significant impact on various sectors of scientific research, including medical marijuana studies. While the Freeze was temporarily stopped, the uncertainty that he has already created has influenced ongoing projects and future research prospects.

Relatives: Veterans with PTBs get a little hope

Medical marijuana research has long faced challenges due to federal restrictions. Despite the growing interest in his therapeutic potential, the classification of marijuana as a medication schedule I under the law on controlled substances limits the research opportunities. In the past, most federal financing for cannabis research focused more on its potential damage than on their medical advantages. The National Institutes of Health (NIH) and the National Institute for Drug Abuse (NIDA) are important players when controlling access to cannabis, which further difficult.

Effects of financing

1. Uncertainty and delayed projects: Financing freezing, even if it is only temporary, has introduced uncertainty into the research environment. Scientists rely on stable funds to plan and carry out long -term studies. Any disorder can delay projects and influence the years of research efforts.
2. Effects on academic freedom: Freezing is considered a threat to academic freedom, as the researchers fear4. This fear can influence medical marijuana research in particular, which is already controversial and underfunded.
3. Restricted access to research materials: The Nida monopoly for cannabis in research level has the historically restricted access to materials that are required for comprehensive studies6. Freezing funds exacerbates this problem by reducing the already limited resources for the acquisition and study of cannabis.
4. Initiatives at state level: While federal financing is of crucial importance, some countries have taken the initiative to finance medical marijuana research. However, these efforts are often not sufficient to compensate for the lack of federal support

The continuing challenges in medical marijuana research underline the need for a consistent and supportive federal policy. Since more states legalize cannabis for medical use, there is growing demand for strict scientific studies in order to validate their effectiveness and security. However, before the federal restrictions are relieved and financing becomes more accessible, progress in this area remains slow.

Federal Finance freezes the existing obstacles to medical marijuana research and further hinders the efforts to examine their therapeutic potential. Coping with these challenges requires a shift in federal politics to support comprehensive and impartial research on the medical services of cannabis.